Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 131 entries
View as:

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT05930028 Org: User:
Start: 07/13/23 End: 09/05/24 Due: 09/05/25

A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06890286 Org: User:
Start: 12/01/24 End: 01/03/25 Due: 01/03/26

Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)

Phase: N/A Priority: Normal
NCT ID: NCT00937651 Org: User:
Start: 04/30/05 End: 06/30/06 Due: 06/30/07

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

Phase: N/A Priority: Normal
NCT ID: NCT06314919 Org: User:
Start: 03/15/24 End: 03/31/26 Due: 03/31/27

A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06649162 Org: User:
Start: 09/30/24 End: 03/31/27 Due: 03/31/28

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02397538 Org: User:
Start: 02/28/15 End: 04/30/15 Due: 04/30/16

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01135212 Org: User:
Start: 04/30/10 End: 05/31/11 Due: 05/31/12

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02566187 Org: User:
Start: 08/31/15 End: 10/31/15 Due: 10/31/16

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04846998 Org: User:
Start: 03/25/21 End: 05/18/21 Due: 05/18/22

A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05970237 Org: User:
Start: 07/26/23 End: 06/30/25 Due: 06/30/26

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02166814 Org: User:
Start: 08/31/14 End: 09/30/15 Due: 09/30/16

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00923533 Org: User:
Start: 03/31/09 End: 08/31/09 Due: 08/31/10

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)

Phase: N/A Priority: Normal
NCT ID: NCT03654677 Org: User:
Start: 09/19/17 End: 01/31/19 Due: 01/31/20

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT00922480 Org: User:
Start: 12/31/08 End: 09/30/09 Due: 09/30/10

Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

Phase: N/A Priority: Normal
NCT ID: NCT02913794 Org: User:
Start: 10/11/16 End: 03/29/18 Due: 03/29/19

Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01671020 Org: User:
Start: 06/30/12 End: 07/31/12 Due: 07/31/13

A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

Phase: N/A Priority: Normal
NCT ID: NCT06165250 Org: User:
Start: 04/17/24 End: 04/30/25 Due: 04/30/26

A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Phase: N/A Priority: Normal
NCT ID: NCT06867497 Org: User:
Start: 02/24/25 End: 10/28/25 Due: 10/28/26

A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05460364 Org: User:
Start: 08/04/22 End: 10/17/22 Due: 10/17/23

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02704702 Org: User:
Start: 03/31/16 End: 06/30/16 Due: 06/30/17

to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02205190 Org: User:
Start: 07/31/14 End: 09/30/14 Due: 09/30/15

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05959486 Org: User:
Start: 07/14/23 End: 08/24/23 Due: 08/24/24

A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06220773 Org: User:
Start: 05/21/24 End: 04/30/25 Due: 04/30/26

Fimasartan Blood Pressure Lowering After Acute Stroke

Phase: N/A Priority: Normal
NCT ID: NCT03231293 Org: User:
Start: 07/28/16 End: 04/05/19 Due: 04/05/20

A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01518998 Org: User:
Start: 08/31/11 End: 11/30/13 Due: 11/30/14